Patent 11065197 was granted and assigned to TherapeuticsMD on July, 2021 by the United States Patent and Trademark Office.
According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.